When Will We Have A Vaccine? What is India's Vaccination Plan

India will be the first country to start Vaccination Drive. The Serum Institute of India's Covishield and Bharat Biotech's Covaxin will be administered in India. 

Pfizer and Moderna vaccine makers have promised that their vaccine has 95% efficacy. The United Kingdom has already started vaccination in the country. There are in total 50 vaccine making companies who got success in the making of the Coronavirus vaccine. 

Here, we'll have a look at the top ranking companies which have the plans for the global roll out. The USA has already initiated to carry out vaccination plan and it has delivered to the states on 14th December, 2020.

Vaccine target product profile WHO has published the target product profiles for COVID-19 vaccines; which describes the preferred and minimally acceptable profiles for human vaccines for long term protection of persons at high ongoing risk of COVID-19. Also, for reactive use in outbreak settings with rapid onset of immunity. 

The Government of India has also published the criteria for prioritization of vaccines for clinical trials.

ALSO READ - IS COVID-19 VACCINE COMPULSORY?

India has initiated the vaccine roll out plan. Few weeks ago, Russia's Sputnik V for Coronavirus was arrived at Hyderabad. Later on in Gandhinagar too. the Government of India has made up the vaccine transportation layout in which it will regulate the vaccine supply to the states.

(Image Source : unsplash.com)

How India is planning the Vaccination?

The Government of India is planning to vaccinate 30 Cr. people in a first phase. The USA, The UK and several other countries have approved the emergency use of the Vaccine. In India, once the government allows the emergency use of Vaccine, the vaccination drive will begin.

India has reported sharp fall out in total number of cases. India's total Covid-19 cases rises to 99,06,165 with 22,065 new infections. 354 new fatalities were reported, taking the death toll to 1,43,709. 

Total active cases are at 3,39,820. Total discharged cases are at 94,22,636 with 34,477 new discharges in the last 24 hours. (As of 14 December, 2020)

As per the Government reports, the frontline workers, healthcare workers and the citizens above 50 years age will assured a vaccine. The reports have stated that the vaccination will served to 100 beneficiaries per day. 

Aftermath, the citizens below the age of 50 with essential co-morbidities like diabetes, blood pressure, cholesterol, etc. will get the vaccine. 

The document, which has been shared with all states, says that only 100 people per session at each site per day are likely to be vaccinated to fight against Covid-19. However, the number of people per session might go up to 200 if logistics allows, the Centre noted. "If in any case, more than 200 people are being vaccinated within a session then a whole team of 5 people will have to be deployed separately to vaccinate."

In final phase, the remaining citizens will assured a vaccine; based on essential co-morbidities and the availability of the Vaccine. The vaccination plan may also differ on the bases of the situation and case count. If situation turns into a severe then the roll out plan will divided for a first phase. 

Self Registration For Covid-19 Vaccine Through Co-WIN App

Now, there is an app called as Co-WIN in which you can register for a vaccine. For registers the medical history will inspected. There are three vaccine makers who have applied for the vaccine candidates in India. Also, Pfizer has applied for the emergency use of their vaccine. Aftermath, reports have stated that the vaccination drive will conducted shortly.

Must Read - HOW PHARMA COMPANIES GET VOLUNTEERS FOR THE VACCINE TRIALS?

The central government has made an app through which it will monitor the entire India's vaccination plan. Co-WIN will available for users with its updated version of Electronic Vaccine Intelligence Network (eVIN). 

All About Co-WIN App For Coronavirus Vaccine Registration

Co-WIN app will be available soon for the people. An app is helpful for the administrators and for the people who are going to receive a vaccine. The state government has already shortened the data of the people in first phase. 

The application is carrying total five sections.

1. The Administrator Section
2. Registration Section
3. Vaccine section
4. Beneficiary Acknowledgement Section
5. Reports

The vaccination will take 30 minutes and 100 people per day will assured a vaccine.

1) Administrator Section

This section is helpful for the administrative peoples who are assuring a vaccine. This section will helpful to create a time periods and sections. The vaccinators and managers will notified through this section.

2) Registration Section

This section is helpful for registering process. It will submit the data of the people to be vaccinated. Vaccinators will upload the data with the help of the local authorities.

3) Vaccine Section

This section is helpful to verify the details of a person and the further vaccination status.

4) Beneficiary Acknowledgment Section

After providing a vaccine, it will send an SMS to the beneficiary. It will also generate the QR Code based certificate after vaccination.

5) Reports Section

It will prepare a report on how many vaccine session were conducted and the number of attendees along with the drop out rate.

Covid-19 Vaccine Effectiveness / Prospects

Talking about the efficacy of Covid-19 vaccine; Pfizer, Moderna and AstraZeneca are the key players. They have created a huge success as they made a vaccine for a pandemic in a very minimal time. 

How effective does Pfizer vaccine is?

Pfizer vaccine has 95% efficacy. 

Moderna has  94.1% efficacy.

Oxford AstraZeneca has 90% efficacy.

FDA Conditions For Approval

FDA is Food and Drug Authority in the USA. The FDA said that the effectiveness of a vaccine should at least 50% in a phase three.

It has said that the trial should be conducted on a large scale of more than 3000 people.

According to the FDA guidelines, monitoring of the participants in the trial should done for more than a month. 

Emergency Authorization of Vaccines (EUA)

Vaccine developers can apply for a fast track process to get the approval of vaccines. 

Emergency Use Authorization (EUA) EUA is granted on the basis of results obtained in the Phase 3 trials. 

They require less data and the 6 month follow up study is bypassed. 

EUA can only be granted in case of a public health emergency.